المؤلفون: Arron, Sarah, Chang, ALS, Arron, ST, Migden, MR, Solomon, JA, Yoo, S, Day, B-M, McKenna, EF, Sekulic, A

URL الوصول: https://escholarship.org/uc/item/3qv5w0gc

المؤلفون: Arron, Sarah, Steenrod, AW, Smyth, EN, Bush, EN, Chang, ALS, Arron, ST, Helfrich, YR, Von, DD, Brail, LH, Coyne, KS

URL الوصول: https://escholarship.org/uc/item/4zc46400

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA., Brown R; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA.; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA; and., Li S; Departments of Dermatology and Urology, Stanford University School of Medicine, Redwood City, CA., Betancourt N; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA., Teng J; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA.

المصدر: The American Journal of dermatopathology [Am J Dermatopathol] 2024 Sep 01; Vol. 46 (9), pp. 588-592. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article; Case Reports

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7911005 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-0311 (Electronic) Linking ISSN: 01931091 NLM ISO Abbreviation: Am J Dermatopathol Subsets: MEDLINE

مواضيع طبية MeSH: Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology , Skin Neoplasms*/metabolism , Carcinoma, Basal Cell*/drug therapy , Carcinoma, Basal Cell*/pathology , Carcinoma, Basal Cell*/metabolism , TOR Serine-Threonine Kinases*/metabolism , TOR Serine-Threonine Kinases*/antagonists & inhibitors , Sirolimus*/pharmacology , Sirolimus*/therapeutic use , Signal Transduction*/drug effects , MTOR Inhibitors*/pharmacology , MTOR Inhibitors*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Adult ; Aged ; Basal Cell Nevus Syndrome/drug therapy ; Basal Cell Nevus Syndrome/pathology ; Basal Cell Nevus Syndrome/metabolism ; Immunohistochemistry ; Antibiotics, Antineoplastic ; Child ; Adolescent ; Young Adult ; Aged, 80 and over ; Proto-Oncogene Proteins c-akt/metabolism ; Off-Label Use ; Treatment Outcome ; Cell Cycle Proteins ; Adaptor Proteins, Signal Transducing

المؤلفون: Tu KY; Division of General Medicine, Taipei Medical University Shuang Ho Hospital, New Taipei, Taiwan., Jung CJ; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., Shih YH; Department of Dermatology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Dermatology, Taipei Medical University Shuang Ho Hospital, New Taipei, Taiwan., Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, United States.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jul 29; Vol. 15, pp. 1403798. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Rosacea*/immunology , Rosacea*/therapy , Neuroinflammatory Diseases*/immunology , Neuroinflammatory Diseases*/etiology, Humans ; Cytokines/metabolism ; Animals ; Skin/immunology ; Skin/pathology

المؤلفون: Peris K; Catholic University Fondazione Policlinico Universitario-IRCCS, Rome, Italy., Inocencio TJ; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Stratigos AJ; National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece., Lewis KD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Eroglu Z; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Chang ALS; Dermatology Department, Stanford University School of Medicine, Redwood City, California, USA., Ivanescu C; IQVIA, Durham, North Carolina, USA., Sekulic A; Mayo Clinic, Scottsdale, Arizona, USA., Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Chen CI; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA., Quek RGW; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.

المصدر: Cancer medicine [Cancer Med] 2024 Jul; Vol. 13 (14), pp. e7360.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life* , Antibodies, Monoclonal, Humanized*/therapeutic use , Carcinoma, Basal Cell*/drug therapy , Carcinoma, Basal Cell*/psychology , Carcinoma, Basal Cell*/pathology, Humans ; Male ; Female ; Middle Aged ; Aged ; Skin Neoplasms/drug therapy ; Skin Neoplasms/pathology ; Skin Neoplasms/psychology ; Adult ; Aged, 80 and over ; Treatment Outcome ; Antineoplastic Agents, Immunological/therapeutic use

المؤلفون: Che Y; Department of Dermatology, Stanford University School of Medicine, Redwood City, California., Chong C; Department of Medical Oncology, Stanford University School of Medicine, Redwood City, California., Limova M; Department of Dermatology, University of California San Francisco, Fresno, California., Morris L; Department of Medical Oncology, Stanford University School of Medicine, Stanford, California., Reddy SA; Department of Medical Oncology, Stanford University School of Medicine, Stanford, California., Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City, California.

المصدر: JAAD case reports [JAAD Case Rep] 2024 Feb 18; Vol. 46, pp. 92-94. Date of Electronic Publication: 2024 Feb 18 (Print Publication: 2024).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101665210 Publication Model: eCollection Cited Medium: Print ISSN: 2352-5126 (Print) Linking ISSN: 23525126 NLM ISO Abbreviation: JAAD Case Rep Subsets: PubMed not MEDLINE

المؤلفون: Stratigos AJ; Department of Dermatology-Venereology, Andreas Sygros Hospital-National and Kapodistrian University of Athens, Athens, Greece. Electronic address: alstrat2@gmail.com., Sekulic A; Department of Dermatology, Arizona Mayo Clinic, Scottsdale, Arizona., Peris K; Dipartimento di Scienze Mediche e Chirurgiche, UOC di Dermatologia, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy., Bechter O; Department of General Medical Oncology, University Hospitals, Leuven, Belgium., Prey S; Department of Dermatology, Bordeaux University Hospital, Bordeaux, France., Lewis KD; School of Medicine, University of Colorado, Aurora, Colorado., Basset-Seguin N; Department of Dermatology, Hôpital Saint-Louis, Paris, France., Chang ALS; Department of Dermatology, Stanford University School of Medicine, Stanford, California., Dalle S; Department of Dermatology, Centre Hospitalier Lyon-Sud, Lyon, France., Fernández Orland A; Department of Dermatology, Hospital Universitario Virgen Macarena, Seville, Spain., Licitra L; Medical Oncology Head and Neck Cancer Department, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Milan, Italy., Robert C; Dermatology Unit, Gustave Roussy Cancer Center and Paris-Saclay University, Villejuif, France., Ulrich C; Skin Cancer Centre, Charite-Universitätsmedizin Berlin, Berlin, Germany., Hauschild A; Department of Dermatology, University of Kiel, Kiel, Germany., Migden MR; Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas., Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Yoo SY; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Okoye E; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Bassukas I; Faculty of Medicine, Department of Skin and Venereal Diseases, School of Health Sciences, University of Ioannina, Ioannina, Greece., Loquai C; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., De Giorgi V; Departments of Dermatology, Human Pathology, and Oncology, University of Florence, Florence, Italy., Eroglu Z; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida., Gutzmer R; Johannes Wesling Medical Center, Ruhr University Bochum, Minden, Germany., Ulrich J; Academic Teaching Hospital of the University Otto von Guericke Magdeburg, Quedlinburg, Germany., Puig S; Dermatology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain., Inocencio TJ; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Chen CI; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., LaFontaine PR; Sanofi, Cambridge, Massachusetts., Seebach F; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Lowy I; Regeneron Pharmaceuticals, Inc, Tarrytown, New York., Fury MG; Regeneron Pharmaceuticals, Inc, Tarrytown, New York.

المصدر: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Feb; Vol. 90 (2), pp. 414-418. Date of Electronic Publication: 2023 Oct 14.

نوع المنشور: Multicenter Study; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Basal Cell*/drug therapy , Carcinoma, Basal Cell*/pathology , Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology , Antibodies, Monoclonal, Humanized*, Humans ; Hedgehog Proteins ; Follow-Up Studies

المؤلفون: Lewis KD; Department of Medicine-Medical Oncology, University of Colorado School of Medicine, Aurora, USA. Electronic address: karl.lewis@regeneron.com., Peris K; Department of Medicine and Translational Surgery, Dermatology, Università Cattolica del Sacro Cuore, Rome; Department of Medical and Surgical Sciences, Dermatology, Fondazione Policlinico Universitario A. Gemelli-IRCCS, Rome, Italy., Sekulic A; Department of Dermatology, Mayo Clinic, Scottsdale, USA., Stratigos AJ; First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece., Dunn L; Department of Medicine, Head and Neck Medical Oncology, Memorial Sloan Kettering Cancer Center, New York., Eroglu Z; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa., Chang ALS; Dermatology Department, Stanford University School of Medicine, Redwood City., Migden MR; Department of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston., Yoo SY; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Mohan K; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Coates E; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Okoye E; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Bowler T; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Baurain JF; Department of Medical Oncology, Cliniques Universitaires Saint-Luc and Université Catholique de Louvain, Brussels., Bechter O; Department of General Medical Oncology, University Hospitals, Leuven, Belgium., Hauschild A; Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Kiel, Germany., Butler MO; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada., Hernandez-Aya L; Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, USA., Licitra L; Department of Medical Oncology Head and Neck Cancer, Istituto Nazionale dei Tumori, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Neves RI; Division of Plastic Surgery, Penn State Milton S. Hershey Medical Center, Hershey., Ruiz ES; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Seebach F; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Goncalves P; Regeneron Pharmaceuticals, Inc., Tarrytown, USA., Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, USA.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Feb; Vol. 35 (2), pp. 221-228. Date of Electronic Publication: 2023 Dec 09.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Carcinoma, Basal Cell*/drug therapy , Carcinoma, Basal Cell*/chemically induced , Skin Neoplasms*/drug therapy , Skin Neoplasms*/pathology , Antibodies, Monoclonal, Humanized*, Adult ; Humans ; Male ; Middle Aged ; Aged ; Female ; Hedgehog Proteins ; Ligands ; Disease Progression ; Amides/therapeutic use

المؤلفون: Sia T; Department of Dermatology, Stanford University School of Medicine, Redwood City., Webb T; Department of Dermatology, Stanford University School of Medicine, Redwood City., Li S; Department of Dermatology, Stanford University School of Medicine, Redwood City.; Department of Urology, Stanford University School of Medicine, Center for Academic Medicine, Palo Alto., Moskatel LS; Department of Neurology and Neurological Sciences, Stanford Health Care, Stanford, CA, USA., Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City.

المصدر: The British journal of dermatology [Br J Dermatol] 2023 Nov 16; Vol. 189 (6), pp. 776-778.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Migraine Disorders*/drug therapy , Rosacea*, Humans ; Calcitonin Gene-Related Peptide ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized